Holdings
Euclidean Capital LLC
As of Sep 30, 2026, Euclidean Capital LLC reported 10 positions worth US$324M. Largest: Vanguard FTSE All-World ex-US Index Fund, iShares MSCI India ETF and ORIC Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Vanguard FTSE All-World ex-US Index Fund | 3.24M | US$269M | new | Sep 30, 2026 |
| iShares MSCI India ETF | 370K | US$17.3M | new | Sep 30, 2026 |
| ORIC Pharmaceuticals, Inc. | 989K | US$13.3M | no change | Sep 30, 2026 |
| Teamshares Inc. | 1.1M | US$7.99M | new | Sep 30, 2026 |
| Foghorn Therapeutics Inc. | 1.57M | US$5.62M | no change | Sep 30, 2026 |
| PMV Pharmaceuticals, Inc. | 2.63M | US$4.39M | no change | Sep 30, 2026 |
| Surrozen, Inc. | 87,696 | US$2.82M | no change | Sep 30, 2026 |
| Alector, Inc. | 1.31M | US$2.42M | no change | Sep 30, 2026 |
| Tenaya Therapeutics, Inc. | 1.02M | US$613K | no change | Sep 30, 2026 |
| Merlin, Inc. | 47,610 | US$89,507 | new | Sep 30, 2026 |